Deep search
Profile Picture
  • All
  • Search
  • Images
  • Videos
  • Maps
  • News
  • Copilot
  • More
    • Shopping
    • Flights
    • Travel
  • Notebook
  • Top stories
  • Sports
  • U.S.
  • Local
  • World
  • Science
  • Technology
  • Entertainment
  • Business
  • More
    Politics
  • Any time
    • Past hour
    • Past 24 hours
    • Past 7 days
    • Past 30 days
  • Best match
    • Most recent

News

Figma, Backers Seek $1 Billion in IPO

Bloomberg · 9h
Figma, Backers Seek $1.03 Billion in IPO After Failed Adobe Deal
Figma Inc. and some of its investors are seeking to raise as much as $1.03 billion in a US initial public offering, as the app design and collaboration software company readies what could be one of the biggest listings of the year.
MarketWatch on MSN · 5h
Figma’s IPO seeks a $13 billion valuation, with a bitcoin investment as a sweetener
Figma sets terms in its upcoming initial public offering, and co-founder Dylan Field could net more than $60 million from selling his personal shares.
SiliconANGLE · 1h
Figma seeking $1B+ IPO that could value it at $16.4B
The company plans to list its shares on the New York Stock Exchange under the ticker symbol “FIG.” Chief Executive Officer Dylan Field has reportedly hinted that Figma could make acquisitions after going public.
4h
Figma IPO could value design software maker at $16 billion
Figma disclosed preliminary results for the second quarter showing revenue growth between 39% and 41% year over year.
The Information
7h
Figma’s IPO May Be Hot, but Its Outlook Is Murky
After two blockbuster tech initial public offerings, investors are positively drooling over Figma’s upcoming listing. The ...
6don MSN
DA Davidson Reaffirms Buy on Adobe (ADBE) After Figma’s Strong S-1 Filing
Adobe Inc. (NASDAQ: ADBE) ranks among the best cloud stocks to buy according to Wall Street analysts. In response to Figma’s ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results
Feedback
© 2025 Microsoft
  • Privacy and Cookies
  • Legal
  • Advertise
  • About our ads
  • Help
  • Feedback
  • Your Privacy Choices
  • Consumer Health Privacy